Human embryo DNA edited to remove disease

September 29, 2017

Chinese researchers have edited DNA in lab-made human embryos through precise “chemical surgery” to remove disease in a world first.

The team at Sun Yat-sen University in Guangdong, China used a technique called base editing to correct a single error out of the three billion “letters” of our genetic code.They altered lab-made embryos to remove the disease beta-thalassemia. The embryos were not implanted.

The team says the approach may one day treat a range of inherited diseases.

Base editing alters the fundamental building blocks of DNA – the four bases adenine, cytosine, guanine and thymine – more commonly known by their respective letters A, C, G and T. All the instructions for building and running the human body are encoded in combinations of those four bases.

The potentially life-threatening blood disorder beta-thalassemia is caused by a change to a single base in the genetic code – known as a point mutation.

The team in China edited it back. They scanned DNA for the error then converted a G to an A, correcting the fault.

The Chinese team is the first to demonstrate the feasibility of curing genetic disease in human embryos by base editor system, said Junjiu Huang, one of the researchers, in an interview.

He said their study opens new avenues for treating patients and preventing babies being born with beta-thalassemia, “and even other inherited diseases”.

The experiments were performed in tissues taken from a patient with the blood disorder and in human embryos made through cloning.

Base editing is an advance on a form of gene-editing known as CRISPR that is already revolutionizing science.

CRISPR breaks DNA. When the body tries to repair the break, it deactivates a set of instructions called a gene. It is also an opportunity to insert new genetic information.

Base editing works on the DNA bases themselves to convert one into another.

Professor David Liu, who pioneered base editing at Harvard University, describes the approach as “chemical surgery”.

He says the technique is more efficient and has fewer unwanted side-effects than CRISPR.

About two-thirds of known human genetic variants associated with disease are point mutations, he said.

“So base editing has the potential to directly correct, or reproduce for research purposes, many pathogenic [mutations],” he added.

The research group at Sun Yat-sen University in Guangzhou hit the headlines before when they were the first to use CRISPR on human embryos.

The study is the latest example of the rapidly growing ability of scientists to manipulate human DNA.

It is provoking deep ethical and societal debate about what is and is not acceptable in efforts to prevent disease.


Category: Education, Features

Comments are closed.